All Stories

  1. Long term results of single high dose Stereotactic Body Radiotherapy in the treatment of primary lung tumors
  2. Comparative effectiveness of multi-fraction stereotactic radiosurgery for surgically resected or intact large brain metastases from non-small-cell lung cancer (NSCLC)
  3. 30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic disease
  4. Preoperative intensity-modulated radiotherapy with a simultaneous integrated boost combined with Capecitabine in locally advanced rectal cancer: short-term results of a multicentric study
  5. Radiation therapy for older patients with brain tumors
  6. Critical decision-making in radiotherapy for early stage breast cancer in a neo-adjuvant treatment era
  7. Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases
  8. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up
  9. Mono- and Bi-weekly Hypofractionated Radiation Therapy for the Treatment of Epithelial Skin Cancer in Very Elderly Patients
  10. Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy: Results
  11. Target delineation and optimal radiosurgical dose for pituitary tumors
  12. Single-Fraction Versus Multifraction (3 × 9 Gy) Stereotactic Radiosurgery for Large (>2 cm) Brain Metastases: A Comparative Analysis of Local Control and Risk of Radiation-Induced Brain Necrosis
  13. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy
  14. Different outcomes among favourable and unfavourable intermediate-risk prostate cancer patients treated with hypofractionated radiotherapy and androgen deprivation therapy
  15. Renin-Angiotensin System Inhibitors Might Help to Reduce the Development of Symptomatic Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer
  16. Adjuvant radiochemotherapy for gastric cancer: Should we use prognostic factors to select patients?
  17. Repeated stereotactic radiosurgery for patients with progressive brain metastases
  18. Potential Role of Single Nucleotide Polymorphisms of XRCC1, XRCC3, and RAD51 in Predicting Acute Toxicity in Rectal Cancer Patients Treated With Preoperative Radiochemotherapy
  19. Hypofractionated stereotactic radiotherapy in combination with bevacizumab or fotemustine for patients with progressive malignant gliomas
  20. Manipulation of radiation-induced bystander effect in prostate adenocarcinoma by dose and tumor differentiation grade: In vitro study
  21. Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO Gastrointestinal Group experience
  22. No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT)
  23. Image guided intensity modulated hypofractionated radiotherapy in high-risk prostate cancer patients treated four or five times per week: analysis of toxicity and preliminary results
  24. Neoadjuvant chemoradiation with concomitant boost radiotherapy associated to capecitabine in rectal cancer patients
  25. Fractionated stereotactic radiosurgery for patients with skull base metastases from systemic cancer involving the anterior visual pathway
  26. Whole brain reirradiation and concurrent temozolomide in patients with brain metastases
  27. Fractionated stereotactic radiosurgery for patients with brain metastases
  28. Image-Guided Hypofractionated Radiotherapy in Low-Risk Prostate Cancer Patients
  29. Cytokines, Fatigue, and Cutaneous Erythema in Early Stage Breast Cancer Patients Receiving Adjuvant Radiation Therapy
  30. Clinical Outcomes of Single Dose Stereotactic Radiotherapy for Lung Metastases
  31. Chemoradiation for anaplastic oligodendrogliomas: clinical outcomes and prognostic value of molecular markers
  32. Clinical and technical characteristics of intraoperative radiotherapy
  33. The importance of lymph node retrieval and lymph node ratio following preoperative chemoradiation of rectal cancer
  34. Radiation therapy after breast reconstruction: outcomes, complications, and patient satisfaction
  35. Image Guided Hypofractionated 3-Dimensional Radiation Therapy in Patients With Inoperable Advanced Stage Non-Small Cell Lung Cancer
  36. Intermediate-risk prostate cancer patients treated with androgen deprivation therapy and a hypofractionated radiation regimen with or without image guided radiotherapy
  37. Stereotactic radiosurgery in elderly patients with brain metastases
  38. Curative radiotherapy in patients with anal cancer: clinical outcomes and prognostic factors in a single-institution experience
  39. Integral Dose and Radiation-Induced Secondary Malignancies: Comparison between Stereotactic Body Radiation Therapy and Three-Dimensional Conformal Radiotherapy
  40. Impact of Different Treatment Approaches on Pregnancy Outcomes in 99 Women Treated for Hodgkin Lymphoma
  41. External-beam radiotherapy and/or HDR brachytherapy in postoperative endometrial cancer patients: clinical outcomes and toxicity rates
  42. Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: Is it better than three dimensional conformal radiotherapy?
  43. Frameless linac-based stereotactic radiosurgery (SRS) for brain metastases: analysis of patient repositioning using a mask fixation system and clinical outcomes
  44. Acute toxicity in 14 patients with locally advanced head and neck squamous cell carcinoma treated with concurrent cetuximab and radiotherapy
  45. Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis
  46. Fractionated stereotactic conformal radiotherapy for large benign skull base meningiomas
  47. Fractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastoma
  48. Primary cutaneous Hodgkin lymphoma
  49. Late morbidity and oncological outcome after radical hypofractionated radiotherapy in men with prostate cancer
  50. Long-term results of 60 patients with pathologic stage I & IIA Hodgkin's disease treated with exclusive mantle radiation therapy
  51. The Radiotherapist’s Point of View
  52. MACOP-B and Involved-Field Radiotherapy Is an Effective and Safe Therapy for Primary Mediastinal Large B Cell Lymphoma
  53. Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma
  54. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients
  55. Retroperitoneal mesenchymal chondrosarcoma mimicking a large retroperitoneal sacral schwannoma
  56. Radiotherapy for nonfunctioning pituitary adenomas: from conventional to modern stereotactic radiation techniques
  57. Long-term follow-up results of postoperative radiation therapy for Cushing’s disease
  58. Radiotherapy and sequential temozolomide compared with radiotherapy with concomitant and sequential temozolomide in the treatment of newly diagnosed glioblastoma multiforme
  59. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas
  60. Detection of Colon Cancer with99mTc-Labeled Bombesin Derivative (99mTc-leu13-BN1)
  61. Long-term outcome after multimodality treatment for stage III thymic tumors
  62. Hodgkin's disease of the nasopharynx: diagnostic and therapeutic approach with a review of the literature
  63. Radiological assessment of necrosis in glioblastoma: variability and prognostic value
  64. Acute nonlymphocytic leukemia: onset after treatment for Hodgkin's disease
  65. Three-Dimensional Computed Tomographic Imaging in the Diagnosis of Vertebral Column Trauma
  66. Supratentorial glioblastoma: neuroradiological findings and survival after surgery and radiotherapy
  68. The Role of Restaging Laparotomy in Hodgkin'S Disease